Kjell Inge Rokke's Aker Biomarine appoints SVP to lead the group’s entry into pharmaceuticals
He will develop and drive growth outside of the company’s core supplement segment, with a focus on pharmaceutical and medical food applications.
He will develop and drive growth outside of the company’s core supplement segment, with a focus on pharmaceutical and medical food applications.